GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...

In ancient Greek lore, Proteus, son of Poseidon, held the allure of wisdom and foresight, yet could only be approached by those with the means to capture him. Much like this mythical figure, proteins, ...

Proteins possess diverse conformations, some pivotal in disease pathology. Protein misfolding and aggregation are linked to neurodegenerative conditions like Alzheimer's, Parkinson’s, and Huntington’s ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

Western blot is one of the most widely applied techniques for protein identification. However, attaining reproducible and reliable results depends on the availability of quality antibodies with ...

Proteins, through their diversity, are vital determinants of phenotype and function. Humans possess potentially millions of protein variants (proteoforms), derived through mechanisms including ...

On Wednesday, Quantum-Si Incorporated (NASDAQ:QSI) stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation (NASDAQ:NVDA) to develop its new ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based ...

Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...

Protein barcodes are short, information- rich stretches of amino acids encoded by DNA sequences that can be added to the DNA sequences coding for proteins. Then, when protein barcode DNA and protein ...